Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03519347 · ClinicalTrials.gov registry record · NA
Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03519347 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 19 participants.
The verdict
NCT03519347, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The primary purpose of this study is to test the feasibility of trials which change the dialysate (dialysis bath prescription) of potassium and bicarbonate according to a standardized algorithm and according to the results of blood testing performed prior to each dialysis. In addition, the trial will provide estimates of the extent to which performing dialysis in this way lowers the risk of abnormal heart rhythms in people with kidney failure who are being treated with chronic hemodialysis.
Interventions
- OTHER Potassium Removal Maximization
- OTHER Potassium Gradient Minimization
- OTHER Alkalosis Avoidance
- OTHER Acidosis avoidance
- DIAGNOSTIC_TEST Point of Care Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-30 |
| Est. Completion | 2022-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03519347
The ClinicalTrials.gov registry entry for NCT03519347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Potassium Removal Maximization is the first listed.
NCT03519347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03519347 about?
NCT03519347 is a clinical study titled "Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A". The primary purpose of this study is to test the feasibility of trials which change the dialysate (dialysis bath prescription) of potassium and bicarbonate according to a standardized algorithm and according to the results of blood testing performed prior to each dialysis. In addition, the trial wil...
What is the current status of trial NCT03519347?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-11-30. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT03519347?
The interventions under investigation include: Potassium Removal Maximization (OTHER), Potassium Gradient Minimization (OTHER), Alkalosis Avoidance (OTHER), Acidosis avoidance (OTHER), Point of Care Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03519347?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.